Treatment of intravenous thrombolysis with half dose recombinant human prourokinase reducing the rate of tirofiban use during early routine catheterization period.

Asian journal of surgery(2022)

Cited 3|Views2
No score
Key words
Catheterization,No-reflow,Percutaneous coronary intervention,Recombinant human prourokinase,Slow flow,Tirofiban
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined